GASDERMIN B (GSDMB) belongs to the novel gene family GASDERMIN (GSDM). All GSDM family members are located in amplicons, genomic regions often amplified during cancer development. Given that GSDMB is highly expressed in cancerous cells and the locus resides in an amplicon, GSDMB may be involved in cancer development and/or progression. However, only limited information is available on GSDMB expression in tissues, normal and cancerous, from cancer patients. Furthermore, the molecular mechanisms that regulate GSDMB expression in gastric tissues are poorly understood. We investigated the spatiotemporal expression patterns of GSDMB in gastric cancer patients and the 5' regulatory sequences upstream of GSDMB. GSDMB was not expressed in the majority of normal gastric-tissue samples, and the expression level was very low in the few normal samples with GSDMB expression. Most pre-cancer samples showed moderate GSDMB expression, and most cancerous samples showed augmented GSDMB expression. Analysis of genome sequences revealed that an Alu element resides in the 5' region upstream of GSDMB. Reporter assays using intact, deleted, and mutated Alu elements clearly showed that this Alu element positively regulates GSDMB expression and that a putative IKZF binding motif in this element is crucial to upregulate GSDMB expression.
INTRODUCTION
Gasdermin B (GSDMB) is a member of the novel gene family Gasdermin (GSDM) that consists of four genes in humans: GSDMA, GSDMB, GSDMC, and GSDMD . The GSDM family was originally identified during searches for causative genes of dominant mouse skin mutants including Recombination-induced mutation 3 (Rim3), all of which exhibit hyper-proliferation and mis-differentiation in the epidermal cells (Sato et al., 1998; Saeki et al., 2000; Runkel et al., 2004; Lunny et al., 2005; Tanaka et al., 2007) . In mice, Gsdma and Gsdmc have both undergone gene duplication and formed gene clusters at two distinct chromosomal regions. Positional cloning of Rim3 revealed that Gsdma3, one of the Gsdma duplicated genes, is causative for Rim3 . All GSDM family members are expressed in a highly tissue-specific manner in both the epithelia of digestive tubes and the epidermis, but their biological function in any tissue remains unclear.
Given the tissue-specific expression patterns of Gsdm genes and the skin phenotypes of mutants in mice, we initially hypothesized that Gsdm genes play a critical role in epithelial cell growth and differentiation. Recently, we generated knockout mice of Gsdmd, which is the solitary member in the mouse Gsdmd subfamily and is expressed mainly in intestinal tract epithelium. Detailed characterization of the mutant phenotype indicated that Gsdmd is not involved in development and terminal differentiation of small intestinal and colonic epithelial cells (Fujii et al., 2008) , but rather it might be involved in homeostasis of epithelial cells. Mice do not have a gene homologous to human GSDMB.
Based on studies of human cancers, it has been inferred that human GSDM family genes might be involved in cancer development and progression. All genes in the GSDM family are located in two cancer-related chromosomal regions, 17q21 and 8q24 (Saeki et al., 2000; Watabe et al., 2001; Katoh 2004a, 2004b; . These regions are frequently amplified in several types of cancer in units referred to as amplicons. We along with other groups reported that expression of GSDMA is frequently suppressed in gastric and skin cancer tissues and cancer-derived cell lines (Saeki et al., 2000; Lunny et al., 2005) . Moreover, it was recently reported that GSDMA is involved in the TGF-beta signaling that mediates apoptosis in the gastric epithelium (Saeki et al., 2007) . In contrast, GSDMB is expressed in human cancer tissues, including gastric, hepatic, colon, uterine, and cervical cancers, and cancer-derived cell lines (Carl-McGrath et al., 2008; Sun et al., 2008) . Although GSDMA and GSDMB belong to the same gene family and are located near to each other on 17q21, expression of GSDMA and GSDMB during cancer development and progression are non-overlapping and complementary. It was reported that there are two different promoters in the cis-regulatory elements of GSDMB, a cellular promoter and a long-terminal-repeat (LTR)derived promoter (Sin et al., 2006; Huh et al., 2008) . These two promoters share all GSDMB exons except for exon1a and exon1b, respectively, but they direct different expression patterns depending on the type of tissue or cancer. According to reports, the LTR-derived promoter directs GSDMB expression in various types of cancer and normal tissues excluding stomach, and the cellular promoter directs expression solely in normal stomach tissues (Sin et al., 2006) . Subsequent reports confirmed the finding on the activity of the LTR-derived promoter (Huh et al., 2008) ; however, the molecular mechanisms by which the cellular promoter regulates GSDMB expression in gastric epithelium have not yet been elucidated.
In this study, we carefully examined the level and pattern of GSDMB expression in cancerous tissues and adjacent normal tissues from cancer patients. We found that a small minority of samples from normal gastric tissues adjacent to cancer lesions expressed GSDMB, and the expression level in these samples was very low. In contrast, strong GSDMB expression was observed in most samples from gastric cancer tissues, and the GSDMB expression level and frequencies of GSDMB-positive samples were positively correlated with the extent of cancer development or progression. We further analyzed genomic sequences upstream of the 5' end of GSDMB to identify cis-elements that regulate this gene in the gastric epithelium. We found an Alu element in the upstream of the GSDMB exon1a that regulates GSDMB expression in the gastric epithelium. Moreover, a putative binding site for IKAROS family zinc finger 1 (IKZF1) in this Alu element was found to be crucial for the GSDMB expression in the gastric epithelium.
MATERIALS AND METHODS
Cancer and normal tissue specimens All cancer, precancer, and normal tissue samples were obtained from patients undergoing surgery at the Department of Surgery, Shizuoka Hospital, Juntendo University School of Medicine. The control samples of normal tissue were taken from the borders of the surgical specimens. All patients consented to have their tumor tissue used for cancer research under a protocol approved by the Institutional Review Board. Additionally, this study was approved by the Human Genome Research Ethics Committee of National Institute of Genetics and by the Medical Research Ethics Committee of Juntendo Shizuoka Hospital, and written informed consent was obtained from all participants.
Expression analysis Protocols for total RNA extraction from cancer cell lines and human tissues (normal, pre-cancer, cancer) and protocols for in situ hybridization were previously described . For in situ hybridization, the open reading frame sequence of GSDMB was used as the template in order to prepare the DIG-labelled probes.
The extracted RNA was treated with RQ1 DNase (Promega). One microgram of the total RNAs and Superscript III Reverse Transcriptase (Invitrogen) were used for the cDNA preparation. PCR reactions were performed as follows: an initial 3 min denaturing step at 94°C followed by 30-35 cycles of 94°C, 60 sec; 60°C, 60 sec; and 72°C, 60 sec. Primer sequences for detection of GSDMB were as follows: 420F, 5'-GGGGACAAGTGGTTA-GATGAA-3'; 1388R, 5'-CAGAGAATTCGTGCCTCAGGG-3', PCR products were resolved on 1% agarose gels.
Alternative splicing products of GSDMB To detect the alternative splicing products of GSDMB, primer sets 562F, 5'-TCCACCATCAGAAAATCAAGA-3'; 955R: 5'-AATCCTCCGAACCCAAAGACT-3' and 710F: 5'-GGA-GACGGTAAAGGAGGAAAC-3'; 1185R: 5'-TACCAAGAC-CCCAGCAGCATT-3' were used for RT-PCR.
To compare the alternative splicing products between normal gastric and cancer tissues, we selectively used the PCR cycles of 40 (normal tissues), 30 (pre-cancer and cancer) or 25 (cancer cell line) cycles. The program used for RT-PCR reactions was as follows: an initial 1 min denaturing step at 94°C followed by selective cycles of 94°C, 30 sec; 57°C, 30 sec; and 72°C, 30 sec. PCR products were resolved on 2.5% agarose gels. 5' Rapid amplification of cDNA ends assay (5' RACE) 5' RACE assays were performed using the 5' RACE system for rapid amplification of cDNA ends kit (Invitrogen) according to the manufacturer's protocols. PCR was also carried out according to the manufacturer's protocols. The PCR products were sub-cloned and sequenced using an ABI Prism 3100 analyzer (Applied Biosystems).
Reporter gene assay
Human cancer cell lines were obtained from RIKEN Bioresource Center Cell Bank (Tsukuba, Japan) or Health Science Research Resources Bank (Osaka, Japan). All of the cell lines were maintained according to the manufacturer's instructions. DNA fragments with various lengths of sequence from the region upstream of GSDMB exon1a were amplified by PCR using human genomic DNA as a template and were subcloned into a pGL3 basic vector (Promega). Searches for transcription factor binding sites were carried out with the MOTIF program (http://motif.genome.jp/). Mutation of the putative LMO2 and IKZF1 binding sites was done by site-directed mutagenesis using a -351 con-struct as a template. The integrity of all constructs was verified by DNA sequencing. One day before transfection, 5 × 10 4 cells were seeded into 24-well plates. Each sample was transfected with 800 ng DNA of the luciferase reporter construct and 40 ng DNA of reference construct pRL-TK (Promega) per well. The cells were harvested from each well after 48 h of transfection, and the luciferase assay was performed using the dual-luciferase reporter assay system (Promega) according to the manufacturer's protocols. All assays were performed in triplicate in each trial and at least three independent trials were conducted for each construct. All results are shown as relative luciferase activity and represent the mean ± S.D.
RESULTS

Correlation between GSDMB expression and gastric cancer development
We examined GSDMB expression in cancer and normal tissues surgically collected from gastric cancer patients. The samples of cancer, precancer (intestinal metaplasia), and normal tissue were collected from each of five patients. In the majority of normal tissue samples, we did not detect GSDMB transcripts by RT-PCR ( Fig. 1A ). Most samples of normal tissue were negative for GSDMB expression, and expression levels were very low in the few normal samples that were GSDMB-positive (Fig. 1A ). Absence or low levels of GSDMB expression were observed in almost all regions of normal tissue, and this finding was not restricted to samples prepared from specific regions of normal tissue. Unlike the normal tissue samples, most pre-cancer and cancer tissue samples were positive for GSDMB expression ( Fig. 1A) . GSDMB expression levels were highest in the cancer samples. This result suggests that GSDMB expression is augmented by cancer development or progression.
To quantify the possible correlation between GSDMB expression level and cancer development or progression, we assayed GSDMB expression in tissue samples from 52 gastric cancer patients. RT-PCR assay showed that 64.6% of the samples from pathologically normal gastric tissue were negative for GSDMB expression (N = 82). GSDMB expression was observed in 84.6% of the samples from cancer tissues (N = 52). We next performed in situ hybridization analysis on the gastric cancer tissues (N = 5) to elucidate which cell type expresses GSDMB. GSDMB is highly expressed in the gastric cancer cells, and it is weakly expressed in the surface mucosa cells of normal gastric tissues ( Fig. 1B-C) .
Alternative splicing transcripts of GSDMB Based on RT-PCR analysis, gastric tissues samples express size variants of GSDMB transcripts (Fig. 2) , as reported by Carl-McGrath et al. (2008) . We detected a single major band in normal tissues with weak GSDMB expression, and sequencing revealed that this band represents the full-length GSDMB transcript. In the pre-cancer and cancer tissues samples and cancer-derived cell lines, we detected several shorter GSDMB transcripts in addition to the full-length transcript. The amount of these shorter mRNAs increased in the cancer tissues and the derivative cancer cell lines. These results indicated that the intensity of the shorter transcripts is positively correlated with the extent of cancer development and progression (Fig. 2) . We subcloned these short GSDMB transcripts and carried out sequencing of the clones, which were derived from patient tissue and cancer cell lines. There are several alternative splicing transcripts of GSDMB. We inferred that the several transcripts encode truncated GSDMB proteins (Acc. No ACB37350, ACB37351, and ACB37352), and it appeared that the alternate splice acceptors occur mostly in the middle part of GSDMB.
GSDMB promoter directing expression in the gastric epithelium Sin et al. (2006) indicated that GSDMB has two promoters, a cellular promoter and an LTRderived promoter and that these promoters are used selectively in normal gastric epithelium and gastric cancer cells, respectively. Although transcriptional activity of the LTR-derived promoter has been defined (Huh et al., 2008) , that of cellular promoter has been elusive (Fig.  3A) . In two gastric cancer cell lines, MKN74 (moderately differentiated adenocarcinoma) and MKN1 (adenosquamous carcinoma), we found weak activity of the Fig. 2 . Tumor progression-associated alternative splicing of GSDMB. RT-PCR showed that GSDMB transcripts have several splice variants (asterisks), which were associated with cancer development and progression. PCR primer sets are indicated to the left of the gel. M: DNA marker, N: normal stomach, P: pre-cancer stomach, C: gastric cancer, CC: gastric cancer cell line, MKN1.
cellular promoter in addition to the strong activity of the LTR-derived promoter (data not shown). Therefore, we examined cellular promoter activity in the MKN74 cell line; 5'-RACE analysis revealed that a GSDMB transcript initiated approximately 1.3 kb upstream of the translation initiation codon in exon2 using the cellular promoter and that this transcript includes exon1a (Fig. 3A) . To define the promoter and cis-acting regulatory sequences that control this transcript, we generated several luciferase reporter constructs and carried out reporter assays using transient transfection of MKN74 cells. A reporter construct with a fragment covering 0.35 kb upstream of the transcriptional start site (TSS) exhibited the highest luciferase activity and a truncated fragment retaining 0.22 kb upstream of the TSS had lower luciferase activity (Fig. 3B) . The same results were obtained with MKN1 cells (data not shown). In contrast, the same construct with the 0.35-kb fragment upstream of the TSS had only a small effect on reporter gene activity in the colonic carcinoma cell line CaCo2, which shows strong GSDMB expression (data not shown). These results indicated that the critical regulatory region for GSDMB expression Fig. 3 . Analysis of GSDMB cellular promoter constructs in MKN74 cell line. (A) Schematic representation of the cellular and LTR-derived promoters responsible for GSDMB expression (Sin et al., 2006) . Translation initiation site is indicated by ATG. Numbers in parentheses show base positions from TSS (+1). (B) Deletion analysis of the GSDMB cellular promoter. Each one of the 5' deletion constructs of the GSDMB promoter region (-4721b, -1908, -482, -351, -220, -171, and -118 to +12) was transiently transfected into MKN74 cells. Luciferase activity for each construct was normalized to that of cells transfected with an empty luciferase vector (Luc) and is shown as relative luciferase activity. All assays were performed in triplicate in each trial and at least three independent trials were conducted for each construct. Mean ± S.D. is shown. (-507 to -208) . Putative LMO2 and IKZF1 binding sites in Alu element are indicated by an upper line and an under line, respectively. Numbers in parentheses show matching score of putative transcription factor binding sequence using the positional weight matrix and Bucher's calculating method (Bucher, 1990) . (B) Schematic representation of the wild-type and mutant reporter constructs. Letters in bold indicate mutated sequences in LMO2 and IKZF1 binding sites. (C) The luciferase activity from the reporter constructs with mutations in LMO2 or IKZF1 binding element was assayed in MKN74 cells. Luciferase activity for each construct was normalized to that of cells transfected with an empty luciferase vector (Luc) and is shown as relative luciferase activity. All assays were performed in triplicate in each trial and at least three independent trials were conducted for each construct. Mean ± S.D. is shown. A mutation in the IKZF1 binding site significantly reduced luciferase activity. (D) Schematic representation of the Aluand LTR-derived promoters of GSDMB.
in the gastric epithelium resides in the 0.35-kb fragment upstream of the TSS.
In parallel, we carried out in silico analysis of sequences upstream of the promoter region and found an Alu element, belonging to the SINE (short-interspersed element) family of repetitive elements, inserted into the site corresponding to -507 to -208 bp from the TSS. We found that the 0.35-kb fragment upstream of the TSS contains Alu-derived sequences that have potential binding sites for the Lim-only 2 (LMO2) and IKZF1 transcription factors (Fig. 4A) . LMO2 belongs to the same family as Lim-only 1 (LMO1), which is reported to act as regulator of GSDMA expression in gastric epithelium (Saeki et al., 2007) . To examine whether the LMO2 and IKZF1 binding sites are involved in regulation of GSDMB expression in the gastric epithelium, we carried out the luciferase reporter assay with a 351-bp fragment upstream of the TSS in transiently transfected MKN74 cells. We used two mutant constructs (AGGCACCTGTAGTCC to AGGC-CCCTGTAGTCC, which disrupts the LMO2 binding site, and GTAGTCCCAGCTACT to GTAGCTCCAGCTACT, which disrupts the IKZF1 binding site, which itself partially overlaps with the LMO2 binding site) and wild-type sequences as a control (Fig. 4B) . The fragment harboring the point mutation in the LMO2 binding site located in the Alu element yielded reporter activity similar to that of the wild-type sequences (Fig. 4C) . In contrast, the mutation in the IKZF1 binding site resulted in significantly reduced reporter activity similar to that seen with a deletion of the whole Alu element (Fig. 4C) . Similar results were obtained in MKN1 cells (data not shown). These results indicated that insertion of repetitive elements created both the LTR-derived promoter and the cellular promoter. Moreover, the cellular promoter was generated by insertion of an Alu element, and the IKZF1 binding site in the Alu element positively regulates GSDMB expression in the gastric epithelium ( Fig. 4D) .
DISCUSSION
Augmented GSDMB expression is correlated with cancer development and progression In this study, we demonstrated that augmented GSDMB expression is associated with the development and progression of gastric cancer in Japanese cancer patients. Curiously, a previous report indicated that expression levels of GSDMB transcripts in cancer tissue samples prepared from European patients are not significantly different from those in non-cancer tissue samples from the same patients (Carl-McGrath et al., 2008) . Although there is no compelling interpretation for this discrepancy, one possibility is that differences in genetic background between Asian and European populations might influence GSDMB expression in cancer tissues.
It was reported that forced expression of full-length GSDMB could neither promote malignant transformation of CHO cells nor confer colony formation ability or carcinogenicity to CHO cells in nude mice (Sun et al., 2008) . These findings suggest that over-expression and ectopic expression of the full-length GSDMB transcript has no effect on cancer development and progression. Given these results, it is notable that GSDMB has several splicing variants (Carl-McGrath et al., 2008) and that some of these transcripts lack the conserved C-terminus of the GSDMB protein . In mice, one of the most severe skin phenotypes is observed in the Gsdma3 mutant allele Gsdma3 Dfl , in which a B2-element insertion results in the production of a truncated Gsdma3 protein (Lunny et al., 2005) similar to the truncated GSDMB protein observed in human gastric cancer cells. Therefore, it is possible that a truncated GSDMB lacking the conserved C-terminus motifs is responsible for induction of hyper-proliferation and/or mis-differentiation of human epithelial cells.
Cis-element to upregulate GSDMB expression in gastric epithelium
In this study, luciferase reporter assay indicated that the IKZF1 binding sequence in an Alu element inserted upstream of the GSDMB exon1 upregulates GSDMB expression in gastric cancer cells. Alu elements are approximately 300-bp-long conserved repeats that belong to the SINE family of retrotransposons, which are found most abundantly in primate genomes. Alu elements are present in more than one million copies and can represent over 10% of wholegenome mass (The BAC Resource Consortium, 2001). Some Alu elements are known to reside in the 5'-flanking regions of genes or within genes and to affect expression of relevant genes in human and mouse (Ferrigno et al., 2001; Batzer and Deininger 2002; Sasaki et al., 2008) . The reporter assays in this study showed that deletion of the whole Alu element did not completely abolish GSDMB expression. Therefore, the Alu element likely acts as a cis-acting element that regulates GSDMB expression rather than a minimum promoter. Alu elements have a dimeric structure with two related but not equivalent monomers, the left and right arms. The left and right arms are separated by Mid-A stretch. The left arm contains functional but weak A and B boxes of the RNA polymerase III internal promoter. Our luciferase assay revealed that the right arm, but not the left arm, activates GSDMB expression in gastric epithelium. Moreover, a mutation introduced into the right arm of Alu element (GTAGTCCCAGCTACT to GTAGCTCCAGCTACT) significantly reduced GSDMB expression. The corresponding wild-type sequence GTAGTCCCAGCTACT showed 85 matching score to a putative binding motif for IKZF1, which is an important regulator of lymphocyte differentiation and acts as a tumor suppressor in T and B cells (Georgopoulos et al., 1994; Winandy et al., 1995) . Reduction of IKZF1 activity induces hyper-proliferation and lymphoma (Winandy et al., 1995) . Although it is unclear whether IKZF1 is involved in gastric cancer development, it is most likely a regulator of GSDMB expression in the gastric epithelium. In addition, we detected IKZF1 transcripts in two different gastric cancer cell lines, MKN1 and MKN74 (data not shown).
In silico analysis of sequences from public genome databases revealed that this Alu element belongs to the AluY subfamily and is found in human, chimpanzee, and orangutan, but not in rhesus monkey or marmoset. These results suggest that insertion of this Alu element occurred after the divergence of orangutans and rhesus monkeys between 25 and 15 million years ago.
Selective use of cis-elements for GSDMB expression
Our results suggest that the cellular and LTR promoters are selectively used for GSDMB expression in normal tissues and cancer tissues. Sin et al. (2006) previously reported that the cellular promoter of GSDMB is used in normal gastric epithelium, whereas the LTRderived promoter is selectively used in the gastric cancer cells. Our results demonstrate that normal stomach epithelial cells do not express GSDMB or express it at very low levels, at least in the Japanese population. In this study, in situ hybridization showed GSDMB expression in some gastric surface mucosa, as is seen in cancer cells ( Fig. 1B-C) . Although sample numbers were small (N = 7), we observed moderate levels of GSDMB expression in most pre-cancer tissue samples obtained from cancer patients ( Fig. 1A and data not shown) . At the pre-cancer stage, both the Alu-and LTR-derived promoters might be active in the stomach epithelium. Promoter switching from the Alu-to the LTR-derived promoter might occur as the pre-cancer tissues progress to cancers, at which point GSDMB expression is strongly augmented in the cancer cells. Therefore, GSDMB expression levels and Alu-versus LTR-derived promoter usage may be good markers of gastric cancer in the evaluation of gastric cancer development and progression in Japanese gastric cancer patients.
In general, cis-elements that are used selectively as cancers progress provide powerful tools that reduce the harmful effects of gene therapy on normal tissues. Thus, the putative IKZF binding motif in the Alu element may serve as a crucial tool in the development of gene therapy strategies for the treatment of gastric cancers.
